ORTHO-GYNOL

Compare ORTHO-GYNOL  to:
Compare
Compare

Generic Name for ORTHO-GYNOL

Octoxynol-9 1% (50mg/applicatorful); contraceptive jelly; contains parabens.

Legal Classification:

OTC

Pharmacological Class for ORTHO-GYNOL

Spermicide.

Manufacturer of ORTHO-GYNOL

Personal Products Co.

Indications for ORTHO-GYNOL

Contraception.

Adult dose for ORTHO-GYNOL

1 teaspoonful spread over the surface and rim of diaphragm prior to intercourse provides 6 hrs protection. Reapply prior to each intercourse (if used with diaphragm do not remove diaphragm; use applicator). Do not remove before 6 hrs following intercourse. Extr Str may be used with condom or alone: 1 applicatorful into vagina up to 1 hr before intercourse and before each additional intercourse. For all: use with each intercourse regardless of day of menstrual cycle.

Children's dosing for ORTHO-GYNOL

Not applicable.

Also:

Warnings/Precautions for ORTHO-GYNOL

Discontinue if irritation occurs.

Adverse Reactions for ORTHO-GYNOL

Local vaginal or penile irritation.

How is ORTHO-GYNOL supplied?

Gynol—2.5oz, 3.8oz (w. applicator)
Gynol Ext Str—2.85g (w. applicator)
Ortho-Gynol—3.8oz (w. applicator)

Related Disease:

Contraception

Related Resources

ella emergency contraceptive available soon

August 16, 2010

Watson announced that ella (ulipristal acetate tablet), an oral emergency contraceptive, will be available in the fourth quarter of 2010 by prescription only.

FDA warns against unapproved intrauterine devices (IUDs)

July 26, 2010

The FDA is warning healthcare professionals not to use unapproved intrauterine devices (IUDs).

Generic Yaz available

June 01, 2010

Teva Pharmaceuticals announced that Gianvi (drospirenone and ethinyl estradiol tablets), a generic version of Bayer's Yaz, has been made available.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.

Natazia approved for the prevention of pregnancy

May 07, 2010

The FDA has approved Natazia (estradiol valerate and estradiol valerate/dienogest, from Bayer Healthcare) tablets for the prevention of pregnancy.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions